Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis

Light Chain ◽

High Dose ◽

Long Term Follow Up ◽

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00561-3 ◽

2021 ◽

Vol 27 (3) ◽

pp. S434-S435

Author(s):

Camille Vanessa Edwards ◽

J. Mark Sloan ◽

Vaishali Sanchorawala

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Light Chain ◽

Older Patients ◽

High Dose ◽

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.06.018 ◽

2018 ◽

Vol 24 (9) ◽

pp. 1823-1827 ◽

Cited By ~ 2

Author(s):

Vina P. Nguyen ◽

Heather Landau ◽

Karen Quillen ◽

Dina Brauneis ◽

Anthony C. Shelton ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Light Chain ◽

High Dose ◽

Light Chain Amyloidosis ◽

Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation

International Journal of Dermatology ◽

10.1111/ijd.13315 ◽

2016 ◽

Vol 55 (10) ◽

pp. e539-e543 ◽

Cited By ~ 13

Author(s):

Ramya Chockalingam ◽

Madeleine Duvic

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

Long Term Follow Up ◽

New Hematologic Response Criteria Predict Survival in Patients With Immunoglobulin Light Chain Amyloidosis Treated With High-Dose Melphalan and Autologous Stem-Cell Transplantation

Journal of Clinical Oncology ◽

10.1200/jco.2013.48.7736 ◽

2013 ◽

Vol 31 (21) ◽

pp. 2749-2750 ◽

Cited By ~ 15

Author(s):

Saulius Girnius ◽

David C. Seldin ◽

Maria Teresa Cibeira ◽

Vaishali Sanchorawala

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Light Chain ◽

Response Criteria ◽

High Dose ◽

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.08.031 ◽

2018 ◽

Vol 24 (1) ◽

pp. 127-132 ◽

Cited By ~ 14

Author(s):

Felipe Batalini ◽

Laura Econimo ◽

Karen Quillen ◽

J. Mark Sloan ◽

Shayna Sarosiek ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Light Chain ◽

High Dose ◽

Monoclonal Immunoglobulin ◽

Monoclonal Immunoglobulin Deposition Disease ◽

Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation

Amyloid ◽

10.1080/13506129.2016.1258356 ◽

2016 ◽

Vol 23 (4) ◽

pp. 254-259

Author(s):

Andrew J. Cowan ◽

Zandra K. Klippel ◽

Philip A. Stevenson ◽

Teresa S. Hyun ◽

Sherilyn Tuazon ◽

...

Keyword(s):

Stem Cell ◽

Light Chain ◽

Progression Free Survival ◽

High Dose ◽

Free Survival ◽

High Dose Melphalan ◽

Novel Agent

Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation

Blood ◽

10.1182/blood-2002-07-2030 ◽

2002 ◽

Vol 100 (7) ◽

pp. 2679-2680 ◽

Cited By ~ 22

Author(s):

Anne Wiesmann ◽

Robert Weissert ◽

Lothar Kanz ◽

Hermann Einsele

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Autologous Blood ◽

High Dose ◽

High Dose Therapy ◽

Long Term Follow Up ◽

Blood Stem Cell Transplantation

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

Haematologica ◽

10.3324/haematol.2014.119198 ◽

2015 ◽

Vol 100 (5) ◽

pp. 677-682 ◽

Cited By ~ 10

Author(s):

B. P. C. Hazenberg ◽

A. Croockewit ◽

B. van der Holt ◽

S. Zweegman ◽

G. M. J. Bos ◽

...

Keyword(s):

Stem Cell ◽

Light Chain ◽

High Dose ◽

Trial Group ◽

Prospective Phase ◽

Amyloid Light Chain ◽

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

Leukemia ◽

10.1038/sj.leu.2404306 ◽

2006 ◽

Vol 20 (9) ◽

pp. 1533-1538 ◽

Cited By ~ 175

Author(s):

P Corradini ◽

C Tarella ◽

F Zallio ◽

A Dodero ◽

M Zanni ◽

...

Keyword(s):

Stem Cell ◽

T Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

T Cell Lymphomas ◽

Long Term Follow Up ◽

Peripheral T Cell Lymphomas

Long-term efficacy of sequential vincristine, adriamycin, and dexamethasone (VAD) and bortezomib, thalidomide, and dexamethasone (VTD) as induction chemotherapy followed by high-dose melphalan with autologous stem cell transplantation (auto-SCT) and bortezomib consolidation: a follow-up study of KMM51

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.07.341 ◽

2015 ◽

Vol 15 ◽

pp. e141-e142

Author(s):

J. Shin ◽

Y. Koh ◽

H.J. Kim ◽

S.-S. Yoon ◽

D.S. Lee ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Induction Chemotherapy ◽

High Dose ◽

Follow Up Study ◽